Galera Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Galera Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2019 to Q2 2024.
  • Galera Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Galera Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $2.79M, a 81.6% decline year-over-year.
  • Galera Therapeutics, Inc. annual Interest Expense for 2023 was $11.4M, a 1.36% decline from 2022.
  • Galera Therapeutics, Inc. annual Interest Expense for 2022 was $11.6M, a 60.8% increase from 2021.
  • Galera Therapeutics, Inc. annual Interest Expense for 2021 was $7.19M, a 47.4% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.79M $0 -$4.4M -100% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $7.19M $0 -$4.22M -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $11.4M $4.88M +$1.56M +46.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $9.86M -$2.09M -$5.33M -164% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $15.2M $4.4M +$1.7M +63% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $13.5M $4.22M +$1.92M +83.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $11.6M $3.32M +$1.01M +43.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $10.6M $3.25M +$918K +39.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $9.64M $2.7M +$1.4M +107% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $8.24M $2.3M +$1.05M +83.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $7.19M $2.31M +$1.06M +84.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 $6.14M $2.33M +$1.09M +88.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.05M $1.3M +$7K +0.54% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $5.04M $1.25M +$158K +14.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $4.88M $1.26M +$317K +33.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $4.56M $1.24M +$317K +34.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $4.25M $1.3M +$559K +76% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $3.69M $1.1M +$656K +149% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $3.03M $938K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $918K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $736K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $439K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.